We describe a new autosomal recessive white matter disorder ('hypomyelination and congenital cataract') characterized by hypomyelination of the central and peripheral nervous system, progressive neurological impairment and congenital cataract. We identified mutations in five affected families, resulting in a deficiency of hyccin, a newly identified 521-amino acid membrane protein. Our study highlights the essential role of hyccin in central and peripheral myelination.
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White matter disorders (WMDs) constitute a heterogeneous group of genetic and acquired diseases predominantly affecting the white matter of the brain. In the last decade, the genetic etiology of several WMDs has been elucidated. Nevertheless, about half of the cases remain without a specific diagnosis 1 . The largest single category among the unclassified WMDs consists of individuals with hypomyelination 2 .
We identified ten individuals from five families characterized by congenital cataract, progressive neurological impairment and diffuse myelin deficiency as shown by brain magnetic resonance imaging (MRI). All individuals presented with bilateral cataract at birth or in the first 2 months of life and underwent ocular surgery. Initial psychomotor development was normal. At the end of the first year of life, development was delayed in all individuals. All achieved the ability to walk only with support. Over time, the individuals experienced slowly progressive pyramidal and cerebellar dysfunction, muscle weakness and wasting prevailingly in the lower limbs and most became wheelchair bound. Mental deficiency ranged from mild to moderate (Supplementary Table 1 online). Brain MRI showed abnormalities consistent with diffuse cerebral hypomyelination 3 , whereas the cortex and deep gray matter structures were preserved (Fig. 1a,b) . Neurophysiological studies demonstrated peripheral neuropathy in nine of the ten individuals. Motor nerve conduction velocity was slightly to markedly slowed depending on the age of individuals, and the amplitude of compound muscle action potentials was also reduced. A sural nerve biopsy, performed in four individuals, showed deficiency of the myelin sheath in several nerve fibers and mild axonal loss, without active axonal degeneration (Fig. 1c,d ). constellation of clinical, neuroradiological, neurophysiological and neuropathological findings was not consistent with any of the known WMDs. Therefore, we hypothesized that it represents a novel autosomal recessive WMD, which we have termed 'hypomyelination and congenital cataract' (HCC).
To identify the causative gene, we performed a genome-wide scan with 10 cM-spaced microsatellite markers in three consanguineous families (families 2, 3 and 5; Supplementary Fig. 1 and Supplementary Methods online). We identified a unique segment of homozygosity on chromosome 7p21.3-p15.3 between markers D7S517 and D7S510. Parametric linkage analysis showed a cumulative maximum lod score of 4.53 (Supplementary Table 2 online). We genotyped the remaining families and found homozygosity for this locus in all individuals. The typing of additional markers refined the critical homozygous region to 4.4 Mb between markers D7S503 and D7S673 ( Supplementary Fig. 1 ). The HCC locus contained 31 transcriptional units, mainly of unknown function. The systematic screening of all transcripts of the critical region led to the identification of two mutations affecting a splice site (IVS2+1G-A (Mut1) in families 1-3 and IVS5+1G-T (Mut2) in family 4) and a missense mutation (158T-C (Mut3) in family 5) in DRCTNNB1A (Fig. 2a and Supplementary Methods).
Mut1 causes skipping of exon 2, which harbors the initiation codon (Fig. 2b) and probably results in the lack of protein production. By introducing a cryptic splice site downstream in intron 5, Mut2 leads to the insertion of a 20-bp intronic segment into the DRCTNNB1A mRNA, resulting in a premature stop codon at position 145 ( Fig. 2b and Supplementary Methods) . Mut3 results in the substitution of a leucine residue with a proline at position 53 of the protein (L53P), without altering the structure of the DRCTNNB1A mRNA (Fig. 2b) . We did not identify these mutations in 400 control chromosomes. Sequence alignment of the protein encoded by human DRCTNNB1A and its homologs in different species indicated that the leucine residue affected by Mut3 is highly conserved throughout evolution (Supplementary Fig. 2 online) . Therefore, the L53P variant is most likely pathogenic.
In order to explore the effect of the identified mutations, we raised polyclonal rabbit antibodies against the N terminus of the protein encoded by human DRCTNNB1A. Immunoblot analysis showed that it is absent or strongly reduced in fibroblast lysates from individuals carrying the three different mutations (Fig. 2c and Supplementary Methods). In individual 10 (Mut3), who is still walking with support at age 20 years and does not have a peripheral neuropathy, a residual amount of the protein is present. These data indicate that HCC is caused by the deficiency of the protein encoded by DRCTNNB1A and suggest a correlation between reduced protein level and phenotypic severity.
DRCTNNB1A encodes a 521-amino acid protein, which we have named hyccin. A search in the protein database showed the presence of putative hyccin orthologs in different species and a human paralog on chromosome 2q33.1 ( Supplementary Fig. 2 ). RNA blot analysis showed that DRCTNNB1A is expressed in several adult tissues and is ubiquitously expressed in the brain ( Supplementary Fig. 3 online) . Using RT-PCR, we also found that DRCTNNB1A is expressed in the lens (Supplementary Fig. 3 ). InterProScan and PROSITE analysis of hyccin did not identify any known functional domains or motifs. TMpred analysis uncovered two putative transmembrane segments ( Supplementary Fig. 4 online), suggesting a membrane localization. DRCTNNB1A has been shown to be downregulated by b-catenin in colon carcinoma (SW480) cells and its expression has been found to be decreased in different colorectal cancer tissues 4 . These findings suggest a potential role of DRCTNNB1A in tumorigenesis. However, the function of DRCTNNB1A has remained unknown 4 .
We next subcloned the full-length wild-type DRCTNNB1A cDNA into a Myc-tagged expression vector and transfected the construct into COS-7 cells. Immunocytochemical staining of the transfected cells with monoclonal antibodies to Myc detected hyccin at the plasma membrane with a patchy distribution (Fig. 2d and Supplementary  Fig. 5 and Supplementary Methods online). We further explored the membrane association of hyccin by cell fractionation 5 . In control fibroblasts, hyccin is present in the particulate fraction containing high-affinity membrane-binding proteins, whereas it is absent in the soluble fraction containing cytosolic or low-affinity membrane binding proteins ( Fig. 2e and Supplementary Methods). These data provide evidence that hyccin is a tightly associated cell membrane protein.
In conclusion, we describe a new autosomal recessive disorder characterized by a central and peripheral myelin deficiency and congenital cataract. We show that this disorder is caused by the defect of a newly identified cell membrane protein encoded by DRCTNNB1A. Our data indicate that hyccin is essential for proper myelination in both the central and peripheral nervous system. The process of myelination is complex and occurs as an interplay between glial cells and neurons. Consequently, the pathogenesis of myelin disorders is highly heterogeneous. A molecular link between cerebral and peripheral myelination disorders and congenital cataract has been provided by gap junctions proteins [6] [7] [8] [9] . The hyccin protein product provides the second molecular link. Recent data indicate that b-catenin-mediated Wnt signaling is involved in both gliogenesis 10, 11 and lens epithelial differentiation 12, 13 . Notably, it has been shown that b-catenin also suppresses the expression of myelin oligodendrocyte markers such as myelin basic protein and proteolipid protein 1 (ref. 11) . Further studies will be required to uncover the role of hyccin and the mechanisms underlying the abnormal myelination in HCC.
Note: Supplementary information is available on the Nature Genetics website.
